S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q3 2022

BVF Partners

Period: Q3 2022 Β· Filed: 2022-11-14
View on SEC EDGAR β†—
AUM
$2.42B
Total portfolio value
Positions
80
Reported securities
Top Holding
MLTX
7.2% $173.1M
QoQ Changes
+4 / -3
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$173.1M7.15%$7.76$18.95+144.2%
7.2%
IONSIONIS PHARMACEUTICALS INC$127.1M5.25%$44.23$81.80+84.9%
5.3%
GHRSGH RESEARCH PLC$107.8M4.45%$11.62$27.01+132.4%
4.5%
KYMRKYMERA THERAPEUTICS INC$102.2M4.22%$21.77$113.51+421.4%
4.2%
RPTXREPARE THERAPEUTICS INC$100.6M4.15%β€”β€”
4.2%
RLAYRELAY THERAPEUTICS INC$97.1M4.01%$22.37$18.65-16.6%
4.0%
CGEMCULLINAN ONCOLOGY INC$96.3M3.98%$12.82$17.63+37.5%
4.0%
RLMDRELMADA THERAPEUTICS INC$76.9M3.18%$37.02$6.28-83.0%
3.2%
CRNXCRINETICS PHARMACEUTICALS IN$72.3M2.98%$19.64$42.23+115.0%
3.0%
RCUSARCUS BIOSCIENCES INC$71.1M2.94%$26.16$30.33+15.9%
2.9%
MRUSMERUS N V$69.0M2.85%β€”β€”
2.9%
THRDTHIRD HARMONIC BIO INC$66.4M2.74%β€”β€”
2.7%
XOMAXOMA CORP DEL$64.7M2.67%$17.91$43.00+140.1%
2.7%
RVMDREVOLUTION MEDICINES INC$64.2M2.65%$19.72$189.24+859.6%
2.6%
ACRSACLARIS THERAPEUTICS INC$62.6M2.59%$15.74$5.56-64.7%
2.6%
CTICCTI BIOPHARMA CORP$51.3M2.12%β€”β€”
2.1%
IDYAIDEAYA BIOSCIENCES INC$49.2M2.03%$14.92$37.65+152.3%
2.0%
KURAKURA ONCOLOGY INC$43.8M1.81%$13.66$11.10-18.7%
1.8%
PNTPOINT BIOPHARMA GLOBAL INC$43.2M1.78%β€”β€”
1.8%
SNDXSYNDAX PHARMACEUTICALS INC$43.2M1.78%$24.03$21.82-9.2%
1.8%
CINCCINCOR PHARMA INC$43.1M1.78%β€”β€”
1.8%
LXRXLEXICON PHARMACEUTICALS INC$38.8M1.60%$2.40$2.32-3.3%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$35.7M1.48%$20.51$19.40-5.4%
1.5%
ITOSITEOS THERAPEUTICS INC$34.5M1.42%β€”β€”
1.4%
XENEXENON PHARMACEUTICALS INC$32.5M1.34%$36.10$60.96+68.9%
1.3%
NUVLNUVALENT INC$32.4M1.34%$19.44$123.73+536.5%
1.3%
FDMT4D MOLECULAR THERAPEUTICS IN$32.2M1.33%$8.04$13.00+61.7%
1.3%
COGTCOGENT BIOSCIENCES INC$31.1M1.28%$14.92$38.69+159.3%
1.3%
ALLKALLAKOS INC$30.6M1.27%β€”β€”
1.3%
EQRXEQRX INC$29.7M1.23%β€”β€”
1.2%

Quarter-on-Quarter Activity

Q3 2022 vs. Q2 2022

New Positions (4)

TickerIssuerNotional
THRDTHIRD HARMONIC BIO INC$66.4M
ALLKALLAKOS INC$30.6M
VERVVERVE THERAPEUTICS INC$22.3M
VIGLVIGIL NEUROSCIENCE INC$16.5M

Exited Positions (3)

TickerIssuerNotional
PTGXPROTAGONIST THERAPEUTICS INC$8.8M
CLDXCELLDEX THERAPEUTICS INC NEW$4.2M
VYGRVOYAGER THERAPEUTICS INC$0.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
EPIXESSA PHARMA INC$4.3M+136.5%
SLNSILENCE THERAPEUTICS PLC$7.0M+126.3%
IONSIONIS PHARMACEUTICALS INC$79.8M+125.1%+84.9%
PNTPOINT BIOPHARMA GLOBAL INC$20.3M+66.0%
RVMDREVOLUTION MEDICINES INC$20.2M+44.3%+859.6%
RLMDRELMADA THERAPEUTICS INC$45.4M+25.3%-83.0%
IDYAIDEAYA BIOSCIENCES INC$10.6M+17.9%+152.3%
LXRXLEXICON PHARMACEUTICALS INC$12.4M+14.1%-3.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
CFRXCONTRAFECT CORP$-12.1M-88.1%
GBIOGENERATION BIO CO$-8.3M-76.7%
EQRXEQRX INC$-20.2M-43.6%
XENEXENON PHARMACEUTICALS INC$-16.1M-43.6%+68.9%
SPROSPERO THERAPEUTICS INC$1.6M-37.6%
RCUSARCUS BIOSCIENCES INC$-29.3M-31.4%+15.9%
SNDXSYNDAX PHARMACEUTICALS INC$-2.1M-23.7%-9.2%
CINCCINCOR PHARMA INC$12.1M-20.2%
← Back to Hedge Funds